Year: 2017
Type: review
Abstract: Long gone is the time when tumors were thought to be insular masses of cells, residing independently at specific sites in an organ. Now, researchers gradually realize that tumors interact with the extracellular matrix (ECM), blood vessels, connective tissues, and immune cells in their environment, which is now known as the tumor microenvironment (TME). It has been found that the interactions between tumors and their surrounds promote tumor growth, invasion, and metastasis. The dynamics and diversity of TME cause the tumors to be heterogeneous and thus pose a challenge for cancer diagnosis, drug design, and therapy. As TME is significant in enhancing tumor progression, it is vital to identify the different components in the TME such as tumor vasculature, ECM, stromal cells, and the lymphatic system. This review explores how these significant factors in the TME, supply tumors with the required growth factors and signaling molecules to proliferate, invade, and metastasize. We also examine the development of TME-targeted nanotheranostics over the recent years for cancer therapy, diagnosis, and anticancer drug delivery systems. This review further discusses the limitations and future perspective of nanoparticle based theranostics when used in combination with current imaging modalities like Optical Imaging, Magnetic Resonance Imaging (MRI) and Nuclear Imaging (Positron Emission Tomography (PET) and Single Photon Emission Computer Tomography (SPECT)).
DOI: 10.3390/ijms18051036
Institutions: Nanyang Technological University, Bharathidasan University
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Keywords: theranostic probes, tumor microenvironment, nanotheranostics, tumor vasculature, extracellular matrix, tumor stromal cells, tumor heterogeneity, metastasis, cancer diagnosis, anticancer drug delivery, nanoparticles, optical imaging, magnetic resonance imaging, positron emission tomography, single photon emission computed tomography
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W2595325397
